{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:06:13Z","timestamp":1793307973590,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In the context of the opioid overdose crisis, understanding the barriers to seeking, attaining and remaining in treatment for patients with opioid use disorder (OUD) is a public health issue. To date, very few studies have assessed the \u201cself-stigma\u201d (i.e., the internalization of negative societal attitudes and stereotypes about oneself, leading to self-judgment) and \u201cperceived stigma\u201d (i.e., the belief that others hold negative attitudes towards oneself due to a particular condition) experienced by patients with OUD receiving opioid agonist treatment (OAT), and none have done so in France. Our study aimed to quantify self-stigma, explore some aspects of perceived stigma, determine the factors associated with greater self-stigma and examine whether the level of self-stigma was related to a delay in seeking care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The STIGMA study was a monocentric, cross-sectional study. The data were collected in a French hospital addiction medicine department. Participants were outpatients with current or past OUD who were still receiving or had received OAT. A questionnaire assessing sociodemographics; OUD characteristics; perceived stigma; and quantification of self-stigma by the Self-Stigma Scale-Short, was administered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 73 questionnaires were included in the analysis. Nearly two-thirds of the patients had a \u201cmoderate to high\u201d level of self-stigma\n                      <jats:bold>.<\/jats:bold>\n                      These patients were significantly younger at OUD onset and were significantly more likely to have at least one dependent child than patients reporting a \u201cvery low to low\u201d level of self-stigma. Nearly half of the participants experienced perceived stigma from a healthcare professional regarding their OUD or OAT, and nearly one-third of the participants were refused care from a healthcare professional because of their OUD or OAT. Moreover, a quarter of the sample reported delaying care due to fear of being stigmatized. We did not find a relationship between self-stigma levels and a delay in seeking care.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study highlights the need to detect stigma and to improve training in addiction medicine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13722-024-00506-1","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T06:02:01Z","timestamp":1729058521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Are the self-stigma and perceived stigma of patients treated with methadone or buprenorphine still a problem fifty years after the marketing authorization for opioid agonist treatment? The observational STIGMA study"],"prefix":"10.1186","volume":"19","author":[{"given":"M\u00e9lanie","family":"Pinhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Schreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Leboucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"STIGMA-group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Abesdris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Barrangou-Pouyes-Darlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Eyzop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Galantai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie Robert","family":"Kunze-","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Pr\u00e9tagut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Verholleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Victorri-Vigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard-Jules","family":"Laforgue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Grall-Bronnec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"issue":"5","key":"506_CR1","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1213\/ANE.0000000000002403","volume":"125","author":"CD Soelberg","year":"2017","unstructured":"Soelberg CD, Brown REJ, Du Vivier D, Meyer JE, Ramachandran BK. The US opioid crisis: current federal and state legal issues. Anesth Analg. 2017;125(5):1675\u201381.","journal-title":"Anesth Analg"},{"key":"506_CR2","unstructured":"Dydyk AM, Jain NK, Gupta M. Opioid use disorder. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Disponible sur: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553166\/."},{"issue":"3","key":"506_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3122\/jabfm.2014.03.130290","volume":"27","author":"LJ Paulozzi","year":"2014","unstructured":"Paulozzi LJ, Zhang K, Jones CM, Mack KA. Risk of adverse health outcomes with increasing duration and regularity of opioid therapy. J Am Board Fam Med. 2014;27(3):329\u201338.","journal-title":"J Am Board Fam Med"},{"issue":"9","key":"506_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo","year":"2021","unstructured":"Santo T, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence. JAMA Psychiat. 2021;78(9):1\u201315.","journal-title":"JAMA Psychiat"},{"key":"506_CR5","unstructured":"ASAM Provider Guide\u2014National Practice Guideline for the Treatment of Opioid Use Disorder\u20142020 Update. Disponible sur: https:\/\/eguideline.guidelinecentral.com\/i\/1224390-national-practice-guideline-for-the-treatment-of-opioid-use-disorder-2020-update\/5?."},{"issue":"12","key":"506_CR6","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","volume":"24","author":"J Ma","year":"2019","unstructured":"Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, et al. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry. 2019;24(12):1868\u201383.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"506_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40263-020-00719-3","volume":"34","author":"E Kelty","year":"2020","unstructured":"Kelty E, Hulse G, Joyce D, Preen DB. Impact of pharmacological treatments for opioid use disorder on mortality. CNS Drugs. 2020;34(6):629\u201342.","journal-title":"CNS Drugs"},{"issue":"1","key":"506_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","volume":"25","author":"GJ MacArthur","year":"2014","unstructured":"MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34\u201352.","journal-title":"Int J Drug Policy"},{"key":"506_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.drugalcdep.2013.10.011","volume":"134","author":"JP Feelemyer","year":"2014","unstructured":"Feelemyer JP, Jarlais DCD, Arasteh K, Phillips BW, Hagan H. Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review. Drug Alcohol Depend. 2014;134:251\u20138.","journal-title":"Drug Alcohol Depend"},{"issue":"2\u20133","key":"506_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.drugalcdep.2011.04.003","volume":"118","author":"B Nosyk","year":"2011","unstructured":"Nosyk B, Guh DP, Sun H, Oviedo-Joekes E, Brissette S, Marsh DC, et al. Health related quality of life trajectories of patients in opioid substitution treatment. Drug Alcohol Depend. 2011;118(2\u20133):259\u201364.","journal-title":"Drug Alcohol Depend"},{"key":"506_CR11","doi-asserted-by":"publisher","first-page":"108221","DOI":"10.1016\/j.drugalcdep.2020.108221","volume":"215","author":"A Jalali","year":"2020","unstructured":"Jalali A, Ryan DA, Jeng PJ, McCollister KE, Leff JA, Lee JD, et al. Health-related quality of life and opioid use disorder pharmacotherapy: a secondary analysis of a clinical trial. Drug Alcohol Depend. 2020;215:108221.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"506_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13011-020-00309-y","volume":"15","author":"CF Aas","year":"2020","unstructured":"Aas CF, Vold JH, Skurtveit S, Lim AG, Ruths S, Islam K, et al. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. Subst Abuse Treat Prev Policy. 2020;15(1):68.","journal-title":"Subst Abuse Treat Prev Policy."},{"issue":"1","key":"506_CR13","doi-asserted-by":"publisher","first-page":"e005997","DOI":"10.1136\/bmjopen-2014-005997","volume":"5","author":"HM Sun","year":"2015","unstructured":"Sun HM, Li XY, Chow EPF, Li T, Xian Y, Lu YH, et al. Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis. BMJ Open. 2015;5(1):e005997.","journal-title":"BMJ Open"},{"issue":"3","key":"506_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/10826089309039624","volume":"28","author":"RR Reno","year":"1993","unstructured":"Reno RR, Aiken LS. Life activities and life quality of heroin addicts in and out of methadone treatment. Int J Addict. 1993;28(3):211\u201332.","journal-title":"Int J Addict"},{"key":"506_CR15","unstructured":"Tableau de bord annuel des traitements de substitution aux opiac\u00e9s\u2014OFDT. Disponible sur: https:\/\/www.ofdt.fr\/statistiques-et-infographie\/tableau-de-bord-annuel-des-traitements-de-substitution-aux-opiaces\/."},{"key":"506_CR16","unstructured":"Slama MR. R\u00f4le des m\u00e9decins g\u00e9n\u00e9ralistes dans la prescription des traitements de substitution aux opiac\u00e9s chez les patients d\u00e9pendants [Th\u00e8se d\u2019exercice]. [France]: Universit\u00e9 Paris 13; 2019."},{"issue":"12\u201314","key":"506_CR17","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.3109\/10826080009148239","volume":"35","author":"J Bell","year":"2000","unstructured":"Bell J. Quality improvement for methadone maintenance treatment. Subst Use Misuse. 2000;35(12\u201314):1735\u201356.","journal-title":"Subst Use Misuse"},{"issue":"12","key":"506_CR18","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1080\/10826084.2022.2115853","volume":"57","author":"E Pasman","year":"2022","unstructured":"Pasman E, Lee G, Kollin R, Rodriguez B, Agius E, Madden EF, et al. Attitudes toward medication for opioid use disorder among substance use treatment providers. Subst Use Misuse. 2022;57(12):1828\u201336.","journal-title":"Subst Use Misuse"},{"issue":"6","key":"506_CR19","first-page":"361","volume":"55","author":"HN Blansfield","year":"1991","unstructured":"Blansfield HN. Addictophobia. Conn Med. 1991;55(6):361.","journal-title":"Conn Med"},{"issue":"3","key":"506_CR20","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.psychres.2013.08.013","volume":"210","author":"C Krajewski","year":"2013","unstructured":"Krajewski C, Burazeri G, Brand H. Self-stigma, perceived discrimination and empowerment among people with a mental illness in six countries: Pan European stigma study. Psychiatry Res. 2013;210(3):1136\u201346.","journal-title":"Psychiatry Res"},{"key":"506_CR21","doi-asserted-by":"publisher","first-page":"110873","DOI":"10.1016\/j.drugalcdep.2023.110873","volume":"249","author":"H Judd","year":"2023","unstructured":"Judd H, Yaugher AC, O\u2019Shay S, Meier CL. Understanding stigma through the lived experiences of people with opioid use disorder. Drug Alcohol Depend. 2023;249:110873.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"506_CR22","doi-asserted-by":"publisher","first-page":"e6102","DOI":"10.1111\/hsc.14047","volume":"30","author":"KKS Chan","year":"2022","unstructured":"Chan KKS, Fung WTW, Leung DCK, Tsui JKC. The impact of perceived and internalised stigma on clinical and functional recovery among people with mental illness. Health Soc Care Community. 2022;30(6):e6102\u201311.","journal-title":"Health Soc Care Community"},{"issue":"8","key":"506_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/070674371205700804","volume":"57","author":"PW Corrigan","year":"2012","unstructured":"Corrigan PW, Rao D. On the self-stigma of mental illness: stages, disclosure, and strategies for change. Can J Psychiatry. 2012;57(8):464\u20139.","journal-title":"Can J Psychiatry"},{"issue":"1","key":"506_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1017\/S1121189X0000261X","volume":"17","author":"C Lauber","year":"2008","unstructured":"Lauber C. Stigma and discrimination against people with mental illness: a critical appraisal. Epidemiol Psichiatr Soc. 2008;17(1):10\u20133.","journal-title":"Epidemiol Psichiatr Soc"},{"issue":"3","key":"506_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.psychres.2004.08.003","volume":"129","author":"JB Ritsher","year":"2004","unstructured":"Ritsher JB, Phelan JC. Internalized stigma predicts erosion of morale among psychiatric outpatients. Psychiatry Res. 2004;129(3):257\u201365.","journal-title":"Psychiatry Res"},{"issue":"12","key":"506_CR26","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.socscimed.2010.09.030","volume":"71","author":"JD Livingston","year":"2010","unstructured":"Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med. 2010;71(12):2150\u201361.","journal-title":"Soc Sci Med"},{"issue":"8","key":"506_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1521\/jscp.2006.25.8.875","volume":"25","author":"PW Corrigan","year":"2006","unstructured":"Corrigan PW, Watson AC, Barr L. The self-stigma of mental illness: implications for self-esteem and self-efficacy. J Soc Clin Psychol. 2006;25(8):875\u201384.","journal-title":"J Soc Clin Psychol"},{"issue":"1","key":"506_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/clipsy.9.1.35","volume":"9","author":"PW Corrigan","year":"2002","unstructured":"Corrigan PW, Watson AC. The paradox of self-stigma and mental illness. Clin Psychol Sci Pract. 2002;9(1):35\u201353.","journal-title":"Clin Psychol Sci Pract"},{"issue":"8","key":"506_CR29","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1017\/S0033291711002558","volume":"42","author":"S Evans-Lacko","year":"2012","unstructured":"Evans-Lacko S, Brohan E, Mojtabai R, Thornicroft G. Association between public views of mental illness and self-stigma among individuals with mental illness in 14 European countries. Psychol Med. 2012;42(8):1741\u201352.","journal-title":"Psychol Med"},{"key":"506_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1037\/0022-0167.54.1.40","volume":"54","author":"DL Vogel","year":"2007","unstructured":"Vogel DL, Wade NG, Hackler AH. Perceived public stigma and the willingness to seek counseling: the mediating roles of self-stigma and attitudes toward counseling. J Couns Psychol. 2007;54:40\u201350.","journal-title":"J Couns Psychol"},{"issue":"12","key":"506_CR31","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1176\/appi.ps.52.12.1621","volume":"52","author":"BG Link","year":"2001","unstructured":"Link BG, Struening EL, Neese-Todd S, Asmussen S, Phelan JC. Stigma as a barrier to recovery: the consequences of stigma for the self-esteem of people with mental illnesses. Psychiatr Serv d\u00e9c. 2001;52(12):1621\u20136.","journal-title":"Psychiatr Serv d\u00e9c"},{"issue":"2","key":"506_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/j.2051-5545.2009.tb00218.x","volume":"8","author":"PW Corrigan","year":"2009","unstructured":"Corrigan PW, Larson JE, R\u00fcsch N. Self-stigma and the \u00abwhy try\u00bb effect: impact on life goals and evidence-based practices. World Psychiatry. 2009;8(2):75\u201381.","journal-title":"World Psychiatry"},{"key":"506_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.breast.2015.10.002","volume":"25","author":"LF Jensen","year":"2016","unstructured":"Jensen LF, Pedersen AF, Bech BH, Andersen B, Vedsted P. Psychiatric morbidity and non-participation in breast cancer screening. Breast. 2016;25:38\u201344.","journal-title":"Breast"},{"issue":"4","key":"506_CR34","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2307\/2657432","volume":"62","author":"S Rosenfield","year":"1997","unstructured":"Rosenfield S. Labeling mental illness: the effects of received services and perceived stigma on life satisfaction. Am Sociol Rev. 1997;62(4):660\u201372.","journal-title":"Am Sociol Rev"},{"issue":"5","key":"506_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00406-019-01074-1","volume":"270","author":"MA Reinhard","year":"2020","unstructured":"Reinhard MA, Dewald-Kaufmann J, W\u00fcstenberg T, Musil R, Barton BB, Jobst A, et al. The vicious circle of social exclusion and psychopathology: a systematic review of experimental ostracism research in psychiatric disorders. Eur Arch Psychiatry Clin Neurosci. 2020;270(5):521\u201332.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"9","key":"506_CR36","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.2105\/AJPH.89.9.1328","volume":"89","author":"BG Link","year":"1999","unstructured":"Link BG, Phelan JC, Bresnahan M, Stueve A, Pescosolido BA. Public conceptions of mental illness: labels, causes, dangerousness, and social distance. Am J Public Health. 1999;89(9):1328\u201333.","journal-title":"Am J Public Health"},{"issue":"3","key":"506_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/02791072.2012.703510","volume":"44","author":"JJ Palamar","year":"2012","unstructured":"Palamar JJ, Kiang MV, Halkitis PN. Predictors of stigmatization towards use of various illicit drugs among emerging adults. J Psychoactive Drugs. 2012;44(3):243\u201351.","journal-title":"J Psychoactive Drugs"},{"issue":"10","key":"506_CR38","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1176\/appi.ps.201400140","volume":"65","author":"CL Barry","year":"2014","unstructured":"Barry CL, McGinty EE, Pescosolido BA, Goldman HH. Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness. Psychiatr Serv. 2014;65(10):1269\u201372.","journal-title":"Psychiatr Serv"},{"issue":"9","key":"506_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/01.NAJ.0000471243.30951.92","volume":"115","author":"Z Paschkis","year":"2015","unstructured":"Paschkis Z, Potter ML. CE: acute pain management for inpatients with opioid use disorder. AJN Am J Nurs. 2015;115(9):24\u201332.","journal-title":"AJN Am J Nurs."},{"key":"506_CR40","first-page":"108","volume":"17","author":"F Etesam","year":"2014","unstructured":"Etesam F, Assarian F, Hosseini H, Ghoreishi F. Stigma and its determinants among male drug dependents receiving methadone maintenance treatment. Arch Iran Med. 2014;17:108\u201314.","journal-title":"Arch Iran Med"},{"issue":"2","key":"506_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.apnu.2020.12.005","volume":"35","author":"S Fontesse","year":"2021","unstructured":"Fontesse S, Rimez X, Maurage P. Stigmatization and dehumanization perceptions towards psychiatric patients among nurses: a path-analysis approach. Arch Psychiatr Nurs. 2021;35(2):153\u201361.","journal-title":"Arch Psychiatr Nurs"},{"key":"506_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","volume":"57","author":"CE Paquette","year":"2018","unstructured":"Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104\u201310.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"506_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/ADM.0000000000000693","volume":"15","author":"SD Kimmel","year":"2021","unstructured":"Kimmel SD, Rosenmoss S, Bearnot B, Larochelle M, Walley AY. Rejection of patients with opioid use disorder referred for post-acute medical care before and after an anti-discrimination settlement in Massachusetts. J Addict Med. 2021;15(1):20\u20136.","journal-title":"J Addict Med"},{"issue":"1","key":"506_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-soc-071312-145702","volume":"41","author":"BA Pescosolido","year":"2015","unstructured":"Pescosolido BA, Martin JK. The stigma complex. Ann Rev Sociol. 2015;41(1):87\u2013116.","journal-title":"Ann Rev Sociol"},{"issue":"12","key":"506_CR45","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3109\/01612840.2015.1074769","volume":"36","author":"BM Lindgren","year":"2015","unstructured":"Lindgren BM, Eklund M, Melin Y, Graneheim UH. From resistance to existence\u2014experiences of medication-assisted treatment as disclosed by people with opioid dependence. Issues Mental Health Nurs. 2015;36(12):963\u201370.","journal-title":"Issues Mental Health Nurs."},{"issue":"5","key":"506_CR46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000328637","volume":"17","author":"U Frischknecht","year":"2011","unstructured":"Frischknecht U, Beckmann B, Heinrich M, Kniest A, Nakovics H, Kiefer F, et al. The vicious circle of perceived stigmatization, depressiveness, anxiety, and low quality of life in substituted heroin addicts. Eur Addict Res. 2011;17(5):241\u20139.","journal-title":"Eur Addict Res"},{"issue":"7","key":"506_CR47","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.addbeh.2006.09.008","volume":"32","author":"JB Luoma","year":"2007","unstructured":"Luoma JB, Twohig MP, Waltz T, Hayes SC, Roget N, Padilla M, et al. An investigation of stigma in individuals receiving treatment for substance abuse. Addict Behav. 2007;32(7):1331\u201346.","journal-title":"Addict Behav"},{"issue":"2\u20133","key":"506_CR48","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/10550887.2015.1059714","volume":"34","author":"JS Woods","year":"2015","unstructured":"Woods JS, Joseph H. Stigma from the viewpoint of the patient. J Addict Dis. 2015;34(2\u20133):238\u201347.","journal-title":"J Addict Dis"},{"issue":"4","key":"506_CR49","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.therap.2016.01.008","volume":"71","author":"F Etcheverrigaray","year":"2016","unstructured":"Etcheverrigaray F, B\u00e9taud C, Feuillet F, Grall-Bronnec M, Jolliet P, Victorri-Vigneau C. Pharmacists\u2019 different profiles characterization about opioid substitution treatments. Therapie. 2016;71(4):379\u201387.","journal-title":"Therapie"},{"issue":"9","key":"506_CR50","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.amp.2021.09.002","volume":"180","author":"P Golay","year":"2022","unstructured":"Golay P, Martinez D, Silva B, Morandi S, Bonsack C. Validation psychom\u00e9trique d\u2019une \u00e9chelle fran\u00e7aise d\u2019auto-stigmatisation aupr\u00e8s d\u2019un \u00e9chantillon de patients souffrant de troubles mentaux: la Self-Stigma Scale-Short (SSS-S). Annales M\u00e9dico-psychologiques revue psychiatrique. 2022;180(9):899\u2013904.","journal-title":"Annales M\u00e9dico-psychologiques revue psychiatrique."},{"key":"506_CR51","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1192\/bjp.bp.106.024638","volume":"190","author":"M King","year":"2007","unstructured":"King M, Dinos S, Shaw J, Watson R, Stevens S, Passetti F, et al. The Stigma Scale: development of a standardised measure of the stigma of mental illness. Br J Psychiatry. 2007;190:248\u201354.","journal-title":"Br J Psychiatry"},{"key":"506_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.drugpo.2019.10.005","volume":"74","author":"MD McCradden","year":"2019","unstructured":"McCradden MD, Vasileva D, Orchanian-Cheff A, Buchman DZ. Ambiguous identities of drugs and people: a scoping review of opioid-related stigma. Int J Drug Policy. 2019;74:205\u201315.","journal-title":"Int J Drug Policy"},{"key":"506_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13011-021-00417-3","volume":"16","author":"L Garpenhag","year":"2021","unstructured":"Garpenhag L, Dahlman D. Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study. Subst Abuse Treat Prev Policy. 2021;16:81.","journal-title":"Subst Abuse Treat Prev Policy."},{"issue":"4","key":"506_CR54","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/pubmed\/fdw138","volume":"39","author":"A Radley","year":"2017","unstructured":"Radley A, Melville K, Easton P, Williams B, Dillon JF. \u00abStanding Outside the Junkie Door\u2019-service users\u00bb experiences of using community pharmacies to access treatment for opioid dependency. J Public Health (Oxf). 2017;39(4):846\u201355.","journal-title":"J Public Health (Oxf)"},{"issue":"2","key":"506_CR55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/13814788.2015.1120286","volume":"22","author":"J Fraeyman","year":"2016","unstructured":"Fraeyman J, Symons L, Van Royen P, Van Hal G, Peremans L. How to overcome hurdles in opiate substitution treatment? A qualitative study with general practitioners in Belgium. Eur J Gen Pract. 2016;22(2):134\u201340.","journal-title":"Eur J Gen Pract"},{"issue":"4","key":"506_CR56","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1071\/PY11100","volume":"18","author":"C Longman","year":"2012","unstructured":"Longman C, Temple-Smith M, Gilchrist G, Lintzeris N. Reluctant to train, reluctant to prescribe: barriers to general practitioner prescribing of opioid substitution therapy. Aust J Prim Health. 2012;18(4):346\u201351.","journal-title":"Aust J Prim Health"},{"key":"506_CR57","unstructured":"Minist\u00e8re du Travail, de la Sant\u00e9 et des Solidarit\u00e9s. Minist\u00e8re du travail, de la sant\u00e9 et des solidarit\u00e9s. Lutter contre les d\u00e9serts m\u00e9dicaux. Disponible sur: https:\/\/sante.gouv.fr\/archives\/masante2022\/lutter-contre-les-deserts-medicaux\/."},{"issue":"6","key":"506_CR58","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.drugpo.2013.04.004","volume":"24","author":"A Chandler","year":"2013","unstructured":"Chandler A, Whittaker A, Cunningham-Burley S, Williams N, McGorm K, Mathews G. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods. Int J Drug Policy. 2013;24(6):e35-42.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"506_CR59","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/AOG.0000000000000991","volume":"126","author":"ME Kremer","year":"2015","unstructured":"Kremer ME, Arora KS. Clinical, ethical, and legal considerations in pregnant women with opioid abuse. Obstetr Gynecol. 2015;126(3):474\u20138.","journal-title":"Obstetr Gynecol"},{"key":"506_CR60","unstructured":"Ndiaye A. Traitements de substitution aux opio\u00efdes en France. Notes de l'OFDT, 4 pages, Mars 2023.ISBN : 979-10-92728-68-2. https:\/\/www.ofdt.fr\/sites\/ofdt\/files\/2023-08\/field_media_document-3251-doc_num--explnum_id-33864-.pdf"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00506-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-024-00506-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00506-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T17:03:30Z","timestamp":1729098210000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-024-00506-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1186\/s13722-024-00506-1","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. The STIGMA study was approved by the local ethics committee (<i>Groupe Nantais d'Ethique dans le Domaine de la Sant\u00e9<\/i>). The participants were informed about this study, and their written consent was systematically collected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}